A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America

Park, 2015, Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study, Liver Int, 35, 2155, 10.1111/liv.12818 Adam, 2012, Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR), J Hepatol, 57, 675, 10.1016/j.jhep.2012.04.015 Thuluvath, 2010, Liver transplantation in the United States, 1999–2008, Am J Transpl, 10, 1003, 10.1111/j.1600-6143.2010.03037.x Wong, 2014, Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S, Hepatology, 59, 2188, 10.1002/hep.26986 Piñero, 2016, Liver transplantation for hepatocellular carcinoma: evaluation of the AFP model in a multicenter cohort from Latin America, Liver Int, 36, 1657, 10.1111/liv.13159 Piñero, 2015, Screening for liver cancer during transplant waiting list, Eur J Gastroenterol Hepatol, 27, 355, 10.1097/MEG.0000000000000272 de Ataide, 2012, Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma, Transpl Proc, 44, 2438, 10.1016/j.transproceed.2012.07.006 Costa, 2014, Ten-year experience with liver transplantation for hepatocellular carcinoma in a federal university hospital in the northeast of Brazil, Transpl Proc, 46, 1794, 10.1016/j.transproceed.2014.05.016 Hoyos, 2015, Factors associated with recurrence and survival in liver transplant patients with HCC – a single center retrospective study, Ann Hepatol, 14, 58, 10.1016/S1665-2681(19)30801-4 Gabrielli, 2015, Liver transplantation results for hepatocellular carcinoma in Chile, Transpl Proc, 42, 299, 10.1016/j.transproceed.2009.11.034 Fassio, 2010, Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study, Ann Hepatol, 9, 63, 10.1016/S1665-2681(19)31681-3 Paranaguá-Vezozzo, 2014, Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort, Ann Hepatol, 13, 386, 10.1016/S1665-2681(19)30845-2 Mazzaferro, 1996, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, N Engl J Med, 334, 693, 10.1056/NEJM199603143341104 Yao, 2002, Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria, Liver Transpl, 8, 765, 10.1053/jlts.2002.34892 Duvoux, 2012, Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria, Gatroenterology, 143, 10.1053/j.gastro.2012.05.052 Yao, 2011, Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?, Liver Transpl, 17, S109, 10.1002/lt.22335 Villanueva, 2011, Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma, Gastroenterology, 140, 10.1053/j.gastro.2011.02.006 Mazzaferro, 2009, Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis, Lancet Oncol, 10, 35, 10.1016/S1470-2045(08)70284-5 Kneteman, 2011, Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation, Liver Transpl, 17, S117, 10.1002/lt.22334 Elm von, 2007, The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies, Lancet, 370, 1453, 10.1016/S0140-6736(07)61602-X Salvalaggio, 2014, Liver transplantation in Latin America, Transplantation, 98, 241, 10.1097/TP.0000000000000198 Younossi, 2016, The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe, Hepatology, 64, 1577, 10.1002/hep.28785 Piscaglia, 2016, Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study, Hepatology, 63, 827, 10.1002/hep.28368 Piñero, 2018, Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina, World J Hepatol, 10, 41, 10.4254/wjh.v10.i1.41 Geissler, 2016, Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial, Transplantation, 100, 116, 10.1097/TP.0000000000000965 Goldberg, 2017, Changes in the prevalence of hepatitis c virus infection, non-alcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplanation, Gatroenterology, 10.1053/j.gastro.2017.01.003 Flemming, 2016, Reduction in liver transplant wait-list in the era of direct-antiviral therapy, Hepatology Binder-Foucard, 2014, French network of cancer registries (Francim). Cancer incidence and mortality in France over the 1980–2012 periods: solid tumors, Rev Epidemiol Sante Publique, 62, 95, 10.1016/j.respe.2013.11.073